Therapeutic Equivalence Study of HCP0910 250/50 Mcg to Seretide 250 Diskus in Asthmatic Patients
Last updated on July 2021Recruitment
- Recruitment Status
- Completed
- Estimated Enrollment
- 48
Summary
- Conditions
- Asthma
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: RandomizedIntervention Model: Crossover AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 20 years and 75 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT01521455
- Collaborators
- Not Provided
- Investigators
- Study Director: Kyung-mi Park, Ph.D Hanmi Pharmaceutical Co.
Get Well Soon